Reviewed,
UniProtKB/Swiss-Prot Q8NB49 (AT11C_HUMAN)
Last modified
July 22, 2008.
Version 58.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Probable phospholipid-transporting ATPase IG EC=3.6.3.1 Alternative name(s): ATPase class I type 11C ATPase IG ATPase IQ ATPase class VI type 11C | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1132 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Catalytic activity | ATP + H(2)O + phospholipid(In) = ADP + phosphate + phospholipid(Out). |
| Subcellular location | |
| Tissue specificity | Widely expressed. |
| Post-translational modification | Phosphorylated upon DNA damage, probably by ATM or ATR. |
| Sequence similarities | Belongs to the cation transport ATPase (P-type) family. Type IV subfamily. |
| Sequence caution | CAI39713.1 sequence differs from that shown. Reason: Erroneous gene model prediction. CAI39714.1 sequence differs from that shown. Reason: Erroneous gene model prediction. CAI39716.1 sequence differs from that shown. Reason: Erroneous gene model prediction. CAI40418.1 sequence differs from that shown. Reason: Erroneous gene model prediction. CAI41444.1 sequence differs from that shown. Reason: Erroneous gene model prediction. CAI41445.1 sequence differs from that shown. Reason: Erroneous gene model prediction. CAI41446.1 sequence differs from that shown. Reason: Erroneous gene model prediction. CAI41447.1 sequence differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Keywords | |
|---|---|
| Cellular component | Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Transmembrane |
| Ligand | ATP-binding Magnesium Metal-binding Nucleotide-binding |
| Molecular function | Hydrolase |
| PTM | Phosphoprotein |
Gene Ontology (GO) | |
| None. [Check GOA] | |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | |||||
| Isoform 1 (identifier: Q8NB49-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | |||||
| Isoform 2 (identifier: Q8NB49-2) The sequence of this isoform differs from the canonical sequence as follows: 1100-1132: RNLSCRRASDSLSARPSVRPLLLRTFSDESNVL → VHHLISSSA | |||||
| Notes: No experimental confirmation available. | |||||
| Isoform 3 (identifier: Q8NB49-3) The sequence of this isoform differs from the canonical sequence as follows: 1100-1132: RNLSCRRASDSLSARPSVRPLLLRTFSDESNVL → NPNLELPMLLSYKHTDSGYS | |||||
| Isoform 4 (identifier: Q8NB49-4) The sequence of this isoform differs from the canonical sequence as follows: 1100-1132: RNLSCRRASDSLSARPSVRPLLLRTFSDESNVL → VTKRLPSSGTSAIFMLSQTSSNHSFSWSE | |||||
| Notes: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | ||||
Molecule processing | ||||||||
|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1132 | 1132 | Probable phospholipid-transporting ATPase IG | |||||
Regions | ||||||||
| Topological domain | 1 – 66 | 66 | Cytoplasmic Potential | |||||
| Transmembrane | 67 – 85 | 19 | Potential | |||||
| Topological domain | 86 | 1 | Extracellular Potential | |||||
| Transmembrane | 87 – 107 | 21 | Potential | |||||
| Topological domain | 108 – 290 | 183 | Cytoplasmic Potential | |||||
| Transmembrane | 291 – 311 | 21 | Potential | |||||
| Topological domain | 312 – 346 | 35 | Extracellular Potential | |||||
| Transmembrane | 347 – 367 | 21 | Potential | |||||
| Topological domain | 368 – 879 | 512 | Cytoplasmic Potential | |||||
| Transmembrane | 880 – 900 | 21 | Potential | |||||
| Topological domain | 901 – 908 | 8 | Extracellular Potential | |||||
| Transmembrane | 909 – 929 | 21 | Potential | |||||
| Topological domain | 930 – 955 | 26 | Cytoplasmic Potential | |||||
| Transmembrane | 956 – 976 | 21 | Potential | |||||
| Topological domain | 977 – 995 | 19 | Extracellular Potential | |||||
| Transmembrane | 996 – 1016 | 21 | Potential | |||||
| Topological domain | 1017 – 1026 | 10 | Cytoplasmic Potential | |||||
| Transmembrane | 1027 – 1047 | 21 | Potential | |||||
| Topological domain | 1048 – 1069 | 22 | Extracellular Potential | |||||
| Transmembrane | 1070 – 1090 | 21 | Potential | |||||
| Topological domain | 1091 – 1132 | 42 | Cytoplasmic Potential | |||||
Sites | ||||||||
| Active site | 412 | 1 | 4-aspartylphosphate intermediate By similarity | |||||
| Metal binding | 819 | 1 | Magnesium By similarity | |||||
| Metal binding | 823 | 1 | Magnesium By similarity | |||||
Amino acid modifications | ||||||||
| Modified residue | 261 | 1 | Phosphotyrosine | |||||
| Modified residue | 445 | 1 | Phosphoserine | |||||
| Modified residue | 1108 | 1 | Phosphoserine By similarity | |||||
Natural variations | ||||||||
| Alternative sequence | 1100 – 1132 | 33 | RNLSC…ESNVL → VHHLISSSA in isoform 2. | |||||
| Alternative sequence | 1100 – 1132 | 33 | RNLSC…ESNVL → NPNLELPMLLSYKHTDSGYS in isoform 3. | |||||
| Alternative sequence | 1100 – 1132 | 33 | RNLSC…ESNVL → VTKRLPSSGTSAIFMLSQTS SNHSFSWSE in isoform 4. | |||||
| Natural variant | 114 | 1 | C → W: dbSNP rs2491014. | |||||
| Natural variant | 157 | 1 | T → I in a colorectal cancer sample; somatic mutation. | |||||
| Natural variant | 931 | 1 | Q → P in a colorectal cancer sample; somatic mutation. | |||||
Experimental info | ||||||||
| Sequence conflict | 537 | 1 | L → P in BAC86377. Ref.3 | |||||
| Sequence conflict | 873 | 1 | I → V in BAC86377. Ref.3 | |||||
Sequences
| ||||||||||||||||||||||||||||||||||||

Clusters with